Retraction
Ginsenoside Rh2 inhibits proliferation and migration of medulloblastoma Daoy by down-regulation of microRNA-31
Paper Information
Record ID:
29383
Author(s):
Journal:
Publication Date:
January 29, 2018
Retraction Date:
June 09, 2021
(4.5 years years ago)
Subjects:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Wiley
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1002/jcb.29977Additional Notes:
https://pubpeer.com/publications/BCE2E492AC819658DCACBBECB03EF6
Citations (19)
19
Total Citations7
Post-Retraction(36.8%)
12
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
5
Within 1 year
0
After 2+ years
680
Days since retraction (latest)
Ginsenoside Rh2 attenuates the progression of non‐small cell lung cancer by sponging <scp>miR</scp>‐28‐5p/<scp>STK4</scp> axis and inactivating Wnt/β‐catenin signaling
Jun Ma, Di Zhao, Dahai Yu et al. (6 authors)
Cancer Medicine
Open Access
Published: Apr 2023
10 citations
10 citations
680 days after retraction
The ways for ginsenoside Rh2 to fight against cancer: the molecular evidences in vitro and in vivo.
Qi‐rui Hu, Yao Pan, Han-cheng Wu et al. (9 authors)
Journal of Ginseng Research
Open Access
Published: Oct 2022
16 citations
16 citations
484 days after retraction
Targeting Epigenetic Regulatory Enzymes for Cancer Therapeutics: Novel Small-Molecule Epidrug Development
Ye Jin, Tianjia Liu, Haoming Luo et al. (5 authors)
Frontiers in Oncology
Open Access
Published: Mar 2022
20 citations
20 citations
292 days after retraction
Ginsenosides in central nervous system diseases: Pharmacological actions, mechanisms, and therapeutics
Jing Lu, Xian Wang, Anxin Wu et al. (7 authors)
Phytotherapy Research
Published: Jan 2022
41 citations
41 citations
232 days after retraction
CN‐3 increases TMZ sensitivity and induces ROS‐dependent apoptosis and autophagy in TMZ‐resistance glioblastoma
Yuye Xue, Yunyang Lu, Guangqiang Sun et al. (8 authors)
Journal of Biochemical and Molecular Toxicology
Published: Dec 2021
8 citations
8 citations
203 days after retraction
The Role of MicroRNAs in Therapeutic Resistance of Malignant Primary Brain Tumors
Ilgiz Gareev, Ozal Beylerli, Yanchao Liang et al. (9 authors)
Frontiers in Cell and Developmental Biology
Open Access
Published: Oct 2021
41 citations
41 citations
120 days after retraction
Ginsenoside Rh2 upregulates long noncoding RNA STXBP5-AS1 to sponge microRNA-4425 in suppressing breast cancer cell proliferation
Jae Eun Park, Hyeon Woo Kim, Sung Hwan Yun et al. (4 authors)
Journal of Ginseng Research
Open Access
Published: Aug 2021
16 citations
16 citations
79 days after retraction
Anti-Tumor Mechanisms Associated With Regulation of Non-Coding RNA by Active Ingredients of Chinese Medicine: A Review
Tianjia Liu, Shuang Hu, Zhidong Qiu et al. (4 authors)
Frontiers in Oncology
Open Access
Published: Feb 2021
12 citations
12 citations
111 days before retraction
Anticancer Activities of Ginsenosides, the Main Active Components of Ginseng
Heeok Hong, Delgerzul Baatar, Seong Gu Hwang
Evidence-based Complementary and Alternative Medicine
Open Access
Published: Feb 2021
57 citations
57 citations
126 days before retraction
A recent overview on ginsenosides as microRNA modulators in the treatment of human diseases.
Tae Kyung Hyun
PubMed
Published: Jan 2021
1 citation
1 citation
159 days before retraction
Pharmacokinetics of Ginsenoside Rh2, the Major Anticancer Ingredient of Ginsenoside H Dripping Pills, in Healthy Subjects
Zhenlei Wang, Rui Liu, Li Chen et al. (7 authors)
Clinical Pharmacology in Drug Development
Published: Oct 2020
15 citations
15 citations
247 days before retraction
Roles of plant‐derived bioactive compounds and related<scp>microRNAs</scp>in cancer therapy
Heng Zou, Yanli Li, Xiaomin Liu et al. (6 authors)
Phytotherapy Research
Published: Sep 2020
37 citations
37 citations
252 days before retraction
Anticancer property of ginsenoside Rh2 from ginseng
Xun Li, Shifeng Chu, Meiyu Lin et al. (11 authors)
European Journal of Medicinal Chemistry
Published: Jul 2020
143 citations
143 citations
331 days before retraction
Natural compounds modulate the crosstalk between apoptosis- and autophagy-regulated signaling pathways: Controlling the uncontrolled expansion of tumor cells
Cornelia Braicu, Oana Zănoagă, Alina‐Andreea Zimța et al. (8 authors)
Seminars in Cancer Biology
Published: Jun 2020
67 citations
67 citations
372 days before retraction
<i>Retracted</i>: Geniposide exhibits anticancer activity to medulloblastoma cells by downregulating microRNA‐373
Zhuo Chen, Weiming Liu, Zhigang Qin et al. (6 authors)
Journal of Biochemical and Molecular Toxicology
Open Access
Published: Feb 2020
12 citations
12 citations
481 days before retraction
Increased antitumor efficacy of ginsenoside Rh<sub>2</sub> via mixed micelles: <i>in vivo</i> and <i>in vitro</i> evaluation
Xiaojing Xia, Jin Tao, Zhuwa Ji et al. (6 authors)
Drug Delivery
Open Access
Published: Jan 2020
16 citations
16 citations
525 days before retraction
MicroRNAs mediate the anti-tumor and protective effects of ginsenosides
Milad Ashrafizadeh, Zahra Ahmadi, Reza Mohammadinejad et al. (5 authors)
Nutrition and Cancer
Published: Oct 2019
17 citations
17 citations
606 days before retraction
Ginsenoside Rh2 Inhibits Migration of Lung Cancer Cells under Hypoxia via mir-491
Yingying Chen, Yuqiang Zhang, Wei Song et al. (6 authors)
Anti-Cancer Agents in Medicinal Chemistry
Published: Jul 2019
35 citations
35 citations
705 days before retraction
NF-κB-regulation of miR-155, via SOCS1/STAT3, is involved in the PM2.5-accelerated cell cycle and proliferation of human bronchial epithelial cells
Tian Xiao, Ling Min, Hui Xu et al. (11 authors)
Toxicology and Applied Pharmacology
Published: Jun 2019
41 citations
41 citations
732 days before retraction
Quick Stats
Total Citations:
19
Years Since Retraction:
4.5 years
Open Access:
Yes
Last Checked:
Jul 24, 2025